US Patent Issued to NUCLEIX on Aug. 5 for "Methods and kits for determining the efficiency of plasma separation from whole blood" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,602, issued on Aug. 5, was assigned to NUCLEIX LTD. (Rehovot, Israel).

"Methods and kits for determining the efficiency of plasma separation from whole blood" was invented by Danny Frumkin (Rehovot, Israel), Adam Wasserstrom (Ness Ziona, Israel) and Revital Knirsh (Rosh HaAyin, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and kits for determining the efficiency of plasma separation from whole blood are provided, using real-time PCR amplification of two amplicons, namely, a short amplicon of e.g. 70-150 bps and a long amplicon of e.g. 350-600 bps. The separation efficiency is determined based on the difference in amplification pattern...